Testing Centella asiatica for memory problems in older adults
Part of Brain & nervous system, Mental health clinical trials.
This Phase 1 study tests whether Centella asiatica (a plant-based supplement) is safe and reaches its intended target in people with mild cognitive impairment or early Alzheimer’s disease. It also checks how it affects memory-related brain measures like MRI scans, which is why multiple scans are required.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 60 and 85 years old and able to do study tests in English
- Have vision and hearing that are enough to complete the tests, and you must be able to undergo multiple MRI scans
- No allergy to Centella asiatica and your depression/suicidal thoughts must be low on screening questionnaires
- Have a BMI between 17 and 35, and your overall health must be stable enough for study procedures
- You must meet study thinking/memory test ranges (MMSE 20–28 and clinical criteria for MCI or probable Alzheimer’s) and have a caregiver/study partner who can attend visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special drink containing medium-chain triglycerides (MCTs, a type of fat) and B vitamins can help support memory and thinking in older adults with mild cognitive impairment (MCI). You would take the drink daily for 18 months and have regular check-ins including memory tests.
This Phase 2 study tests whether CBD (a cannabis-derived product) can improve thinking and memory in people who are at risk for Alzheimer’s disease. You would be followed for about 24 weeks with memory/thinking check-ins and require a study partner to help with certain assessments.
This study tests a new medication, CORT108297, that may help protect the brain from the harmful effects of stress in people at risk for Alzheimer's disease. It is looking for adults age 55 and older who either have mild memory problems or are healthy but have a family history, APOE4 gene, or memory concerns.
This trial studies a non-medication (non-drug) program to improve memory and daily thinking in people with mild cognitive impairment or mild Alzheimer’s disease. It may help by supporting brain function and monitoring symptoms over time.
This trial tests an approach to improve learning and memory in people age 60+ with amnestic mild cognitive impairment (a specific type of early memory problem). It may help by supporting memory and learning skills, but it also has medication and health-history requirements.
This trial tests whether a natural extract from ginkgo biloba can help people with mild memory or thinking problems caused by small vessel disease in the brain. It looks for adults aged 50 to 75 who have had these symptoms for at least 3 months but can still live independently.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.